Top Cities for Pediatric Epilepsy Clinical Trials
Pediatric Epilepsy clinical trials are recruiting across 10 cities. Here are the cities with the most active studies:
About Pediatric Epilepsy
Pediatric epilepsy encompasses seizure disorders in children, with many unique syndromes specific to childhood. Epilepsy affects about 0.5-1% of children. Treatment includes antiseizure medications, ketogenic diet, and surgery for drug-resistant cases.
Clinical trials are advancing new treatments for pediatric epilepsy. Currently, 1 studies are recruiting a combined 100 participants across the United States. Research is being conducted by 1 organizations including Eisai Inc..
2026 Pediatric Epilepsy Research Landscape
As of March 2026, the pediatric epilepsy clinical trial landscape includes 1 actively recruiting studies across 10 cities in the United States. These studies are collectively seeking 100 participants, with an average enrollment target of 100 per study.
Research is being led by 1 organization, including Eisai Inc..
Geographically, pediatric epilepsy trials are most concentrated in Phoenix, Arizona (1 trial); Tucson, Arizona (1 trial); Los Angeles, California (1 trial); Aurora, Colorado (1 trial); Wilmington, Delaware (1 trial) and 5 other cities.
Featured Pediatric Epilepsy Studies
Highlighted recruiting studies for pediatric epilepsy, selected by enrollment size and research scope.
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
The purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core study for seizure frequency in participants with pediatric epileptic syndrome (Cohort 1) and partial-onset seizures (POS) (Cohort 2).
Frequently Asked Questions About Pediatric Epilepsy Clinical Trials
Are there pediatric epilepsy clinical trials near me?
Yes, there are 1 pediatric epilepsy clinical trials currently recruiting across 10+ cities in the United States, including Phoenix, Arizona; Tucson, Arizona; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a pediatric epilepsy clinical trial?
To join a pediatric epilepsy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pediatric epilepsy clinical trials free?
Yes, participation in pediatric epilepsy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pediatric epilepsy treatments are being studied?
Current pediatric epilepsy clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in pediatric epilepsy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 2, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov